Custom Complex N-linked Oligosaccharides Synthesis
Overview
CD BioGlyco has extensive experience in the synthesis of custom complex N-linked Oligosaccharides. The unique technology platforms and professional researchers of our company ensure that we offer high-efficient services at a competitive price for our clients. We have the confidence to help our clients accelerate their research on glycobiology by reducing project costs and timelines.
Key Technologies
CD BioGlyco employs state-of-the-art chemo-enzymatic synthesis, a powerful approach that merges the flexibility of chemical synthesis with the unparalleled regio- and stereoselectivity of enzymatic reactions. This synergy allows for the precise construction of complex N-glycans, overcoming limitations often encountered with purely chemical or enzymatic methods.
Our core technologies revolve around:
Glycosyltransferases (GTs)
These enzymes are central to our synthesis, catalyzing the formation of glycosidic bonds by transferring saccharides from activated donors to specific acceptors. The increasing availability and characterization of recombinant GTs allow for the installation of diverse glycoside linkages, enabling the preparation of specific N-glycan epitopes and the creation of complex, multi-antennary structures. Our capabilities extend to working with both commercially available and in-house expressed recombinant GTs.
Glycosidases (GHs) and Glycosynthases
While glycosidases typically hydrolyze glycosidic bonds, engineered variants known as glycosynthases retain the ability to form new glycosidic bonds while suppressing unwanted hydrolysis reactions. This innovative technology is crucial for efficient glycan assembly and for tailoring existing glycan structures. For instance, we utilize glycosynthases, such as engineered endo-β-N-acetylglucosaminidases (ENGases), to precisely attach structurally defined homogeneous N-glycans to glycoproteins, a vital step in producing homogeneous therapeutic proteins like monoclonal antibodies (mAbs).
Optimized Sugar Donors
The availability and stability of activated sugar donors, such as nucleotide sugars (e.g., UDP-GlcNAc, GDP-Fuc, CMP-Sia), are critical for efficient glycosylation. We employ strategies to overcome challenges associated with expensive or unstable sugar donors, including the use of multi-enzyme catalyzed one-pot reactions and in situ sugar nucleotide regeneration systems. We also explore the use of non-natural sugar donors and analogs to expand the scope and flexibility of N-glycan synthesis, enabling the creation of novel glycan structures with enhanced properties.
Automated Synthesis Platforms
For increased efficiency and reproducibility, we integrate automated solid-phase synthesis strategies where appropriate. This approach simplifies purification steps and accelerates the synthesis of complex oligosaccharides, ensuring high-throughput capabilities for diverse project requirements.
Background
N-linked oligosaccharide is characterized by the attachment of glycans to an asparagine side chain of the protein. The glycosylation site of N-linked oligosaccharides is Asn-X-Ser/Thr, where X represents any amino acid except proline. N-linked oligosaccharides have important biological significance, including enhancing solubility and stability of protein, acting as signal molecules in protein folding and transportation, determining the specificity of membrane receptors in cell-to-cell interactions or innate immunity, and changing the properties of hormones and secreted proteins.
The biosynthesis of N-linked glycans occurs through 3 major steps: synthesis of dolichol-linked precursor oligosaccharides, en bloc transfer, and initial trimming of precursor oligosaccharides in the endoplasmic reticulum (ER), and Subsequent processing in the Golgi apparatus. At present, multi-step Chemical or biological synthesis of N-linked oligosaccharides with various structures is the main effective way to obtain N-linked oligosaccharides by artificial strategy, which is of great significance to study the relationship between saccharides and disease.
Fig.1 Different stages of N-glycan complexity. (Fisher, 2016)
Services
Equipped with advanced technology platforms and professional research teams in the field of glycobiology, CD BioGlyco has established effective chemical or chemoenzymatic methods to synthesize high-purity N-linked oligosaccharides for our customers. The services we provide include but are not limited to:
- Characterization and profiling of N-linked oligosaccharides.
- Synthesis of various N-linked oligosaccharides by effective and concise chemical methods.
- Synthesis of complex N-linked oligosaccharides through the chemoenzymatic method according to clients' demands.
- Various modifications of N-linked oligosaccharides according to customers' scientific requirements.
- Purity and quality detection of customized synthesized N-linked oligosaccharides.
Workflow
Our custom complex N-linked oligosaccharide synthesis follows a meticulously designed workflow to ensure the highest quality and precision for your research and development needs. Our process is adaptable to diverse project requirements, from initial design to final product delivery.
Consultation and Design
The process begins with an in-depth consultation to understand your specific requirements. Our expert team collaborates with you to define the target N-glycan structure, purity specifications, quantity, and any specific applications. We leverage our extensive knowledge of N-glycan structures and synthesis strategies to design the most efficient and effective chemo-enzymatic route for your custom oligosaccharide.
Precursor Preparation
Depending on the target glycan, we either chemically synthesize key N-glycan modular structures or prepare N-glycan precursors from natural sources through enzymatic digestion.
Enzymatic Elongation and Modification
This is the core of our chemo-enzymatic approach. Using a carefully selected panel of highly specific GTs and engineered glycosidases, we sequentially add monosaccharide units to the precursor. This step allows for precise control over glycosidic linkages and branching patterns, enabling the creation of diverse and complex N-glycan structures, including those with sialylation and fucosylation.
Purification and Characterization
Following synthesis, the custom N-glycans undergo rigorous purification processes to achieve the desired purity level. This often involves techniques such as high-performance liquid chromatography (HPLC) and other advanced chromatographic methods. Subsequently, comprehensive characterization is performed using techniques like mass spectrometry and nuclear magnetic resonance (NMR) to confirm the exact structure, purity, and integrity of the synthesized oligosaccharide.
Quality Control and Delivery
Each batch of custom N-glycans undergoes stringent quality control checks to ensure it meets the highest standards and client specifications. Upon successful validation, the product is prepared for delivery, accompanied by a detailed certificate of analysis.

Publication Data
DOI.: 10.3390/biom10040624
Journal: Biomolecules
IF: 4.8
Published: 2020
Results: This review article explores the structural mechanisms of N-linked glycosylation catalyzed by the enzyme OST across different domains of life. It highlights how high-resolution structures (particularly recent cryo-EM structures of yeast and human OST complexes) reveal that the catalytic subunit Stt3/STT3 (and its bacterial/archaeal counterparts PglB/AglB) employs a conserved "carboxamide twist" mechanism. In this mechanism, two key acidic residues (e.g., D56 and E319 in bacterial PglB) activate the acceptor asparagine side chain by forming hydrogen bonds with its amide protons, facilitating nucleophilic attack on the lipid-linked oligosaccharide (LLO) donor. The review contrasts the simple single-subunit OST in prokaryotes with the complex multi-subunit OST assemblies in eukaryotes (yeast OST and mammalian OST-A/OST-B isoforms), discussing the roles of non-catalytic subunits and the distinct functions of human OST-A (primary co-translational glycosylation) versus OST-B (proofreading missed sites). Overall, the structures provide insights into sequon recognition, catalytic metal ion coordination, and the evolutionary conservation of the core glycosylation machinery.
Advantages
- Our chemo-enzymatic approach ensures exceptional regio- and stereoselectivity, delivering structurally defined homogeneous N-glycans.
- By leveraging optimized enzymatic reactions, our methods often circumvent the need for extensive protecting group strategies and harsh reaction conditions typically associated with chemical synthesis.
- We offer highly customized synthesis services, working closely with clients to meet their exact specifications for N-glycan structures, quantities, and purity levels.
Application
- Our homogeneous N-glycans are essential for detailed investigations into the biological roles of glycans, including their involvement in protein folding, cell-cell recognition, and signal transduction pathways.
- Access to defined N-glycan structures is crucial for the development of glycan-based therapeutics, vaccines, and diagnostics.
- Custom N-glycans serve as invaluable standards and probes for the discovery and validation of novel glycan biomarkers for early disease detection, diagnosis, and prognosis.
Associated Services
To further support your research and development in glycobiology, we offer a suite of complementary services and related products that can seamlessly integrate with our custom complex N-linked oligosaccharide synthesis offerings.
Glycoprotein Analysis Services
Beyond synthesis, we provide comprehensive analytical services for glycoproteins, including glycan profiling, site-specific glycosylation analysis, and glycopeptide mapping.

Cell-based N-Glycan Array
For high-throughput screening of glycan-binding proteins or antibodies, We assist in the development of custom glycan arrays utilizing our diverse library of synthesized oligosaccharides.

Frequently Asked Questions
CD BioGlyco has successfully synthesized a variety of complex N-linked oligosaccharides through multi-step synthesis. We have the confidence to offer custom complex types of N-glycans synthesis service with high quality for our clients. If you are interested in our services, please contact us for more detailed information.
References
- Fisher, P.; Ungar, D. Bridging the gap between glycosylation and vesicle traffic. Frontiers in Cell and Developmental Biology. 2016, 4:15. (Open Access)
- Mohanty, S.; et al. Structural insight into the mechanism of N-linked glycosylation by oligosaccharyltransferase. Biomolecules. 2020, 10(4): 624. (Open Access)
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




